Search Results - "de Ridder, C.M.A."

Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation by Schäfer, A, Pahnke, A, Schaffert, D, van Weerden, W M, de Ridder, C M A, Rödl, W, Vetter, A, Spitzweg, C, Kraaij, R, Wagner, E, Ogris, Manfred

“…The epidermal growth factor receptor (EGFR) is upregulated within a high percentage of solid tumors and hence is an attractive target for tumor-targeted…”
Get more information

48 Lack of Clinical Efficacy of the Combination of Lenalidomide Plus Docetaxel is Predicted by the Lack of Effect in the Orthotopic PC346C Xenograft Model by van Weerden, W.M, Meulenbeld, H, Boer, A, Stuurman, D, Aghai, A, de Ridder, C.M.A, de Wit, R

Get full text

A1149 - Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer by Van Hemelryk, A., Tomljanovic, I., Erkens-Schulze, S., Teubel, W.J., De Ridder, C.M.A., Stuurman, D.C., Van Royen, M.E., Van Weerden, W.M.

Get full text

Patient-derived organoids represent intra- and interindividual heterogeneity in castration-resistant prostate cancer by Van Hemelryk, A., Tomljanovic, I., Erkens-Schulze, S., Teubel, W.J., De Ridder, C.M.A., Stuurman, D.C., Van Royen, M.E., Van Weerden, W.M.

Get full text

Standardization of viability assays and high-content live-cell imaging protocols for large-scale drug testing in prostate cancer PDX-derived organoids by Van Hemelryk, A., Erkens-Schulze, S., Lam, L., Stuurman, D., de Ridder, C.M.A., French, P.J., van Royen, M.E., van Weerden, W.M.

Get full text

Patient-derived xenografts and organoids recapitulate castration-resistant prostate cancer with sustained androgen receptor signaling by Van Hemelryk, A., Tomljanovic, I., Stuurman, D., de Ridder, C.M.A., Teubel, W.J., Erkens-Schulze, S., van de Werken, H.J.G., van Royen, M., Grudniewska, M., Jenster, G.W., van Weerden, W.M.

Get full text

Cabazitaxel efficacy is strongly enhanced by continued Androgen Receptor Targeted Agents (ARTA) in Castration-Resistant Prostate Cancer (CRPC) by Mout, L., Van Royen, M.E., De Ridder, C.M.A., Stuurman, D., Marques, R.B., De Geer, W.S., Van De Werken, H.J.G., Mathijssen, R.H.J., De Wit, R., Lolkema, M.P., Van Weerden, W.M.

Get full text

Patient-derived preclinical models of castration resistant prostate cancer: Xenografts and PDX-derived organoids to recapitulate patients’ disease profiles by Van Hemelryk, A., Tomljanovic, I., De Ridder, C.M.A., Stuurman, D., Erkens-Schulze, S., Teubel, W.J., Verhoef, E.I., Van Leenders, G.J.L.H., Cangiano, M., Beumer, I.J., Van De Werken, H.J.G., Van Royen, M.E., Grudniewska, M., Van Weerden, W.M.

Get full text

277 AR driven growth in CRPC depends predominantly on androgen precursors secreted by the adrenal gland by Moll, J.M, Teubel, W, Hofland, J, De Ridder, C.M.A, Taylor, A.E, Arlt, W, Greaser, R, Jenster, G, Van Weerden, W.M

Get full text

A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer by Magnusson, M K, Kraaij, R, Leadley, R M, De Ridder, C M A, van Weerden, W M, Van Schie, K A J, Van der Kroeg, M, Hoeben, R C, Maitland, N J, Lindholm, L

“…The efficacy of adenovirus (Ad)-based gene therapy of solid tumors, such as prostate cancer, is limited. One of the many problems is that the virus infects…”
Get more information

O16 - Immunogenomic analysis reveals that tumor aggressiveness is associated with a decreased CD8 T cell signature in an in vivo prostate cancer model by van Gelder, M.A., Marques, R., De Ridder, C.M.A., Stuurman, D.S., Berrevoets, C., Debets, J.E.M.A., Van Weerden, W.M.

Get full text

Immunogenomic analysis reveals that tumor aggressiveness is associated with a decreased CD8 T cell signature in an in vivo prostate cancer model by van Gelder, M.A., Marques, R., De Ridder, C.M.A., Stuurman, D.S., Berrevoets, C., Debets, J.E.M.A., Van Weerden, W.M.

Get full text

22 Nieuw in-vivo-progressiemodel voor castratieresistent prostaatcarcinoom by Moll, J.M., Teubel, W.J., de Ridder, C.M.A., Jenster, G.W., van Weerden, W.M.

“…Samenvatting Castratieresistent prostaatcarcinoom (CRPC) kan worden behandeld met de hormoonsynthese (CYP17A1) remmer abiraterone, of het antiandrogeen…”
Get full text

P64 - Radiosensitivity of patient-derived xenograft tissue slices versus organoids in prostate cancer by Zhang, W., Van Hemelryk, A., De Ridder, C.M.A., Erkens-Schulze, S., Stuurman, D., Van Gent, D.C., Nonnekens, J., Van Weerden, W.M.

Get full text

Radiosensitivity of patient-derived xenograft tissue slices versus organoids in prostate cancer by Zhang, W., Van Hemelryk, A., De Ridder, C.M.A., Erkens-Schulze, S., Stuurman, D., Van Gent, D.C., Nonnekens, J., Van Weerden, W.M.

Get full text

P50 - A novel panel of patient-derived preclinical models of prostate cancer: xenografts and PDX-derived organoids to recapitulate patients disease profiles by Van Hemelryk, A., De Ridder, C.M.A., Erkens-Schulze, S., Teubel, W.J., Stuurman, D., Mc Kinney, C., Cangiano, M., Beumer, I.J., Van Weerden, W.M.

Get full text

A novel panel of patient-derived preclinical models of prostate cancer: xenografts and PDX-derived organoids to recapitulate patients disease profiles by Van Hemelryk, A., De Ridder, C.M.A., Erkens-Schulze, S., Teubel, W.J., Stuurman, D., Mc Kinney, C., Cangiano, M., Beumer, I.J., Van Weerden, W.M.

Get full text

Establishment of prostate cancer organoids: tips, tricks and pitfalls by Van Hemelryk, A., Teubel, W.J., De Ridder, C.M.A., Erkens-Schulze, S., Mout, L., Van Royen, M.E., Van Weerden, W.M.

Get full text

P-31 - Establishment of prostate cancer organoids: tips, tricks and pitfalls by Van Hemelryk, A., Teubel, W.J., De Ridder, C.M.A., Erkens-Schulze, S., Mout, L., Van Royen, M.E., Van Weerden, W.M.

Get full text

581 Lycopene, alone or combined with vitamin E, reduces orthotopic growth and plasma PSA release of PC-346C prostate tumors by Limpens, J., Schröder, F.H., de Ridder, C.M.A., Bolder, C.A., Wildhagen, M.F., Obermüller-Jevic, U.C., Nowakowsky, B., Krämer, K., van Weerden, W.M.

Get full text